Cargando…

Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources

L-tryptophan metabolism is involved in the regulation of many important physiological processes, such as, immune response, inflammation, and neuronal function. Indoleamine 2, 3-dioxygenase 1 (IDO1) is a key enzyme that catalyzes the first rate-limiting step of tryptophan conversion to kynurenine. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Ying, Liu, Miaomiao, Li, Ming, Chen, Yujuan, Ren, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672321/
https://www.ncbi.nlm.nih.gov/pubmed/36408235
http://dx.doi.org/10.3389/fphar.2022.1046818
_version_ 1784832706812575744
author Tan, Ying
Liu, Miaomiao
Li, Ming
Chen, Yujuan
Ren, Meng
author_facet Tan, Ying
Liu, Miaomiao
Li, Ming
Chen, Yujuan
Ren, Meng
author_sort Tan, Ying
collection PubMed
description L-tryptophan metabolism is involved in the regulation of many important physiological processes, such as, immune response, inflammation, and neuronal function. Indoleamine 2, 3-dioxygenase 1 (IDO1) is a key enzyme that catalyzes the first rate-limiting step of tryptophan conversion to kynurenine. Thus, inhibiting IDO1 may have therapeutic benefits for various diseases, such as, cancer, autoimmune disease, and depression. In the search for potent IDO1 inhibitors, natural quinones were the first reported IDO1 inhibitors with potent inhibitory activity. Subsequently, natural compounds with diverse structures have been found to have anti-IDO1 inhibitory activity. In this review, we provide a summary of these natural IDO1 inhibitors, which are classified as quinones, polyphenols, alkaloids and others. The overview of in vitro IDO1 inhibitory activity of natural compounds will help medicinal chemists to understand the mode of action and medical benefits of them. The scaffolds of these natural compounds can also be used for further optimization of potent IDO1 inhibitors.
format Online
Article
Text
id pubmed-9672321
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96723212022-11-19 Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources Tan, Ying Liu, Miaomiao Li, Ming Chen, Yujuan Ren, Meng Front Pharmacol Pharmacology L-tryptophan metabolism is involved in the regulation of many important physiological processes, such as, immune response, inflammation, and neuronal function. Indoleamine 2, 3-dioxygenase 1 (IDO1) is a key enzyme that catalyzes the first rate-limiting step of tryptophan conversion to kynurenine. Thus, inhibiting IDO1 may have therapeutic benefits for various diseases, such as, cancer, autoimmune disease, and depression. In the search for potent IDO1 inhibitors, natural quinones were the first reported IDO1 inhibitors with potent inhibitory activity. Subsequently, natural compounds with diverse structures have been found to have anti-IDO1 inhibitory activity. In this review, we provide a summary of these natural IDO1 inhibitors, which are classified as quinones, polyphenols, alkaloids and others. The overview of in vitro IDO1 inhibitory activity of natural compounds will help medicinal chemists to understand the mode of action and medical benefits of them. The scaffolds of these natural compounds can also be used for further optimization of potent IDO1 inhibitors. Frontiers Media S.A. 2022-11-04 /pmc/articles/PMC9672321/ /pubmed/36408235 http://dx.doi.org/10.3389/fphar.2022.1046818 Text en Copyright © 2022 Tan, Liu, Li, Chen and Ren. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Tan, Ying
Liu, Miaomiao
Li, Ming
Chen, Yujuan
Ren, Meng
Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources
title Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources
title_full Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources
title_fullStr Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources
title_full_unstemmed Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources
title_short Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources
title_sort indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672321/
https://www.ncbi.nlm.nih.gov/pubmed/36408235
http://dx.doi.org/10.3389/fphar.2022.1046818
work_keys_str_mv AT tanying indoleamine23dioxygenase1inhibitorycompoundsfromnaturalsources
AT liumiaomiao indoleamine23dioxygenase1inhibitorycompoundsfromnaturalsources
AT liming indoleamine23dioxygenase1inhibitorycompoundsfromnaturalsources
AT chenyujuan indoleamine23dioxygenase1inhibitorycompoundsfromnaturalsources
AT renmeng indoleamine23dioxygenase1inhibitorycompoundsfromnaturalsources